Search the Newsreel

OSHKOSH ($OSK) Releases Q2 2026 Earnings

Oshkosh Corp reported strong consolidated sales of $2.9 billion for Q2 2026, marking a 6.7% increase, and significant free cash flow improvement to $348 million. Despite this growth, adjusted operating income decreased due to unfavorable mix and higher manufacturing costs, leading to a revised …

Oshkosh Corp. (OSK) Tops Q2 EPS by 24c

Oshkosh Corp. (OSK) announced its Q2 earnings, reporting an EPS of $2.87, which exceeded analyst estimates by $0.24. The company's revenue for the quarter was $2.92 billion, also surpassing the consensus estimate of $2.8 billion.

Oshkosh Corporation Reports 2026 Second Quarter Results

Reports Second Quarter Sales of $2.92 billion, up 6.7 Percent Reports Second Quarter Earnings per Share of $2.92 and Adjusted1 Earnings per Share of $2.87 Updates Outlook for 2026 Earnings per Share to Approximately $10.50 and Adjusted1 Earnings per Share to Approximately $11.00 OSHKOSH, …

Oshkosh Corp (OSK) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Oshkosh Corp (OSK), showing its current valuation score is 8.54, ranking 78 out of 180 in its industry. The company's P/E ratio is 17.15, which is significantly below its recent high and above its recent low. Other …

Oshkosh Q2 Earnings Call Highlights

Oshkosh (NYSE: OSK) Q2 profit dips, cash flow turns positive

Oshkosh (OSK) Stock Faces Margin Squeeze After Lowered EPS Outlook

Oshkosh (NYSE:OSK) Reports Strong Q2 CY2026, Full-Year Sales Guidance is Optimistic

Oshkosh (NYSE:OSK) Reports Strong Q2 CY2026, Full-Year Sales Guidance is Optimistic Specialty vehicles contractor Oshkosh (NYSE:OSK) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 6.7% year on year to $2.92 billion. The company's full-year revenue guidance of $11.2 billion …

Oshkosh (NYSE:OSK) Issues Quarterly Earnings Results, Beats Estimates By $0.26 EPS

Glaukos Announces Completion of Patient Enrollment in 510(k) Pivotal Study for PRESERFLO™ MicroShunt

Glaukos Corporation announced the completion of patient enrollment in its U.S. 510(k) pivotal study for the PRESERFLO™ MicroShunt. This device is designed to treat primary open-angle glaucoma in patients who have not responded to previous medical and surgical treatments. The company aims to use …

Oshkosh Corp (OSK) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Oshkosh Corp (OSK), listing major institutional shareholders and their proportional holdings. It also provides a breakdown of shareholder types and a historical overview of institutional shareholding, including quarterly changes in the number of institutions and shares held.

JinkoSolar Holding Co., Ltd. Sponsored ADR Revenue Breakdown – HAN:ZJS1

JinkoSolar Holding Co., Ltd. (ZJS1) generated €7.97 billion in revenue last year, with its Photovoltaic Products segment contributing the most at €7.41 billion. China was the largest regional contributor, accounting for €2.68 billion last year, a decrease from €4.19 billion the previous year. The …

Tsakos Energy Navigation Ltd (TEN) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of dividends and stock splits for Tsakos Energy Navigation Ltd (TEN). It details dividend payout dates, amounts, and ex-dividend dates, showing that TEN has distributed $213.70 million in dividends over the past five years. The article also lists …

Glaukos completes enrollment in pivotal trial of PRESERFLO MicroShunt for treatment-resistant glaucoma

Glaukos Corporation has successfully completed patient enrollment for its US pivotal study of the PRESERFLO MicroShunt, a device designed to treat advanced glaucoma in patients who have not responded to prior incisional or cilioablative surgeries. The trial included over 110 patients across the US …

Oshkosh (OSK) Reports Q2: Everything You Need To Know Ahead Of Earnings

Oshkosh (OSK) Reports Q2: Everything You Need To Know Ahead Of Earnings Specialty vehicles contractor Oshkosh (NYSE:OSK) will be announcing earnings results this Tuesday before market open. Here's what investors should know. Oshkosh beat analysts' revenue expectations last quarter, reporting revenues of $2.32 billion, …

TEN|Tsakos Energy Navigation Ltd|Price:39.180|Chg%:-0.220

This article provides a comprehensive stock analysis of Tsakos Energy Navigation Ltd (TEN), highlighting its healthy fundamentals, high growth potential, and status as a high dividend payer. The company's stock is considered fairly valued and has received "Buy" ratings from multiple analysts with a …

Glaukos Corp Revenue Breakdown – BX:GKOS

Glaukos Corporation (BX:GKOS) generated 402.28 million CHF last year, with its Glaucoma segment being the top performer, contributing 333.81 million CHF. The United States was the largest geographical contributor, accounting for 297.32 million CHF of the company's revenue. This financial data highlights the company's …

Kosmos Energy (NYSE:KOS) Shares Gap Down - Here's What Happened

Kosmos Energy (NYSE:KOS) shares gapped down at market open, falling from $2.63 to $2.44 before settling at $2.52 on high volume. This decline follows the company reporting a quarterly loss of $0.07 per share, missing estimates by $0.15, and revenue of $370.7 million, which …

Koss Corp (KOSS) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Koss Corp (KOSS), breaking down operating, investing, and financing activities. It includes historical data spanning many fiscal quarters, allowing users to evaluate the company's financial health and stability over time. The document …

Glaukos completes enrollment with at least 110 glaucoma patients

Glaukos Corporation announced the completion of patient enrollment in its U.S. 510(k) pivotal study for the PRESERFLO MicroShunt, a device designed to lower intraocular pressure in patients with primary open-angle glaucoma who had previous unsuccessful treatments. The study enrolled at least 110 patients and …

How PRESERFLO Trial Enrollment Completion Could Shape Glaukos’ (GKOS) Long-Term Glaucoma Pipeline Strategy

Glaukos recently completed patient enrollment for its PRESERFLO MicroShunt trial, moving the device closer to potential FDA submission. This milestone, along with the recent iDose TR labeling update, helps diversify Glaukos' long-term glaucoma pipeline. However, the company still faces challenges with profitability, R&D costs, …

Kosmos Energy (KOS) Expected to Post Quarterly Earnings on Monday

Kosmos Energy (KOS) is anticipated to release its Q2 2026 earnings before market open on Monday, August 3rd, with analysts forecasting earnings of $0.09 per share and revenue of approximately $478.8 million. This outlook follows a Q1 loss and lower-than-expected revenue, contributing to a …

Tsakos Energy Navigation (TEN) Could Be 14% Undervalued On Shuttle Tanker Delivery

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Tsakos Energy Navigation (TEN) drew investor attention after announcing the delivery of the DP2 suezmax shuttle tanker Anfield DP, the third of 12 vessels under …

Koss Corp (KOSS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Koss Corp's (KOSS) dividend and stock split history, noting that no dividends have been distributed in the past five years. It presents key financial information, including the current stock price, market capitalization, and P/E TTM. The page also …

Koss Corp - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance | TradingKey

This article provides a detailed company profile for Koss Corp (KOSS), including its business scope in the audio/video industry, product offerings like high-fidelity headphones and wireless speakers, and its distribution channels. It also presents key financial data such as market capitalization and current stock …

JinkoSolar Holding Co Ltd (JKS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for JinkoSolar Holding Co Ltd (JKS), categorized by business segments and geographic regions. It highlights that sales of solar modules constitute the vast majority of the company's revenue at 96.49%, followed by sales of other solar materials. …

JinkoSolar Holding Co Ltd (JKS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on the historical dividend payouts for JinkoSolar Holding Co Ltd (JKS), noting that the company has distributed $547.69 million in dividends over the past five years. It lists upcoming and recent dividend dates, including ex-dividend, record, and payment dates for …

JinkoSolar Holding Co Ltd (JKS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of JinkoSolar Holding Co Ltd's (JKS) shareholder structure, including major shareholders, institutional holdings, and an overview of shareholder types. It lists top individual and corporate shareholders, institutional investor activity over recent quarters, and related ETF holdings. The data …

Koss Corp (KOSS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Koss Corp (KOSS), outlining major individual and institutional holdings. It includes a breakdown of shareholder types, institutional shareholding over several quarters, and recent shareholder activity. Key shareholders like Michael J. Koss and Vanguard Capital Management are identified, …

Glaukos Corp - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance

Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on treatments for glaucoma, corneal disorders, and retinal diseases, with its Glaucoma business being the largest revenue generator. The article provides a detailed company profile, including financial data, market performance, executive information, and …

Oshkosh Corp (OSK) Q2 2026 Earnings Call Highlights: Strong Sales Growth Amid Operational Challenges

Oshkosh Corp reported strong consolidated sales of $2.9 billion for Q2 2026, marking a 6.7% increase, and significant free cash flow improvement to $348 million. Despite this growth, adjusted operating income decreased due to unfavorable mix and higher manufacturing costs, leading to a revised …

JinkoSolar Holding Co Ltd (JKS) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for JinkoSolar Holding Co Ltd (JKS), detailing various volatility metrics, drawdown figures, and liquidity indicators. It covers performance over different periods, including daily returns, Sharpe Ratio, and maximum drawdown, offering a comprehensive overview of the stock's risk profile …

Oshkosh Corporation $OSK Shares Bought by Sei Investments Co.

Sei Investments Co. increased its stake in Oshkosh Corporation (NYSE:OSK) by 2.8% in Q1, bringing its total holdings to 404,156 shares valued at $59.5 million. Institutional ownership of Oshkosh remains high at 92.36%, with other major investors also increasing their positions. Analysts maintain a …

Tsakos Energy Navigation Ltd (TEN) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Tsakos Energy Navigation Ltd (TEN), identifying its major shareholders, including the Tsakos Holdings Foundation and Sea Consolidation SA of Panama, and categorizing shareholder types such as corporations, hedge funds, and investment advisors. It also provides a historical …

Cooper Creek Partners Management LLC Takes Position in Tsakos Energy Navigation Ltd $TEN

Oshkosh Corp Revenue Breakdown – LSE:0KDI

Oshkosh Corp's last year's revenue was $10.42 billion USD, with the Access segment contributing the most at $4.49 billion USD. Geographically, the United States was the largest contributor, accounting for $8.56 billion USD of the total revenue.